TESSARA Trademark

Trademark Overview


On Tuesday, March 17, 2020, a trademark application was filed for TESSARA with the United States Patent and Trademark Office. The USPTO has given the TESSARA trademark a serial number of 79289716. The federal status of this trademark filing is REGISTERED as of Tuesday, May 25, 2021. This trademark is owned by Tessara Therapeutics Pty Ltd. The TESSARA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research and development; biotechnology research and development; analysis of human tissues for medical research; biological sample analysis for scientific and medical research purposes; product development of diagnostic apparatuses; pharmaceutical drug development services; pharmaceutical research and development; product development consultancy relating to research and development in the field of therapeutics; medical, scientific, and new product research in the field of gene therapy; providing new products testing, quality testing and safety testing in the fields of scientific and medical research relating to research and development of medicines, drug discovery, pharmaceutical drug development and drug screening for scientific research purposes and consultancy related thereto; scientific research relating to the isolation and cultivation of human tissues and cells
tessara

General Information


Serial Number79289716
Word MarkTESSARA
Filing DateTuesday, March 17, 2020
Status700 - REGISTERED
Status DateTuesday, May 25, 2021
Registration Number6358467
Registration DateTuesday, May 25, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 9, 2021

Trademark Statements


Goods and ServicesScientific research and development; biotechnology research and development; analysis of human tissues for medical research; biological sample analysis for scientific and medical research purposes; product development of diagnostic apparatuses; pharmaceutical drug development services; pharmaceutical research and development; product development consultancy relating to research and development in the field of therapeutics; medical, scientific, and new product research in the field of gene therapy; providing new products testing, quality testing and safety testing in the fields of scientific and medical research relating to research and development of medicines, drug discovery, pharmaceutical drug development and drug screening for scientific research purposes and consultancy related thereto; scientific research relating to the isolation and cultivation of human tissues and cells

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 21, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTessara Therapeutics Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAU

Party NameTessara Therapeutics Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAU

Party NameTessara Therapeutics Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events


Event DateEvent Description
Friday, March 10, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, October 4, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, September 16, 2021FINAL DISPOSITION NOTICE SENT TO IB
Thursday, September 16, 2021FINAL DISPOSITION PROCESSED
Wednesday, August 25, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 25, 2021REGISTERED-PRINCIPAL REGISTER
Monday, March 15, 2021NOTIFICATION PROCESSED BY IB
Tuesday, March 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 9, 2021PUBLISHED FOR OPPOSITION
Wednesday, February 24, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 24, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 2, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 2, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 1, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 1, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 27, 2020REFUSAL PROCESSED BY IB
Saturday, September 5, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, August 26, 2020REFUSAL PROCESSED BY MPU
Saturday, July 25, 2020APPLICATION FILING RECEIPT MAILED
Wednesday, July 22, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, July 21, 2020NON-FINAL ACTION WRITTEN
Tuesday, July 21, 2020ASSIGNED TO EXAMINER
Tuesday, July 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 16, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB